Introduction: Dysphagia is often caused by radiotherapy (RT) in patients with head and neck cancer (HNC), and reduced tongue pressure (TP) is often associated with swallowing dysfunction in the oral stage. However, the evaluation of dysphagia by measuring TP has not yet been established in HNC patients. Herein, we conducted a clinical trial to evaluate the usefulness of TP measurement using a TP-measuring device as an objective indicator of dysphagia induced by RT in HNC patients. Methods and Analysis: This ELEVATE trial is a prospective, single-center, single-arm, non-blind, non-randomized trial to evaluate the usefulness of a TP measurement device for dysphagia associated with the treatment of HNC. Eligible participants include patients with oropharyngeal or hypopharyngeal cancer (HPC) undergoing RT or chemoradiotherapy (CRT). The TP measurements are conducted before, during, and after RT. The primary endpoint is the change in the maximum TP values from before RT to 3 months after RT. Moreover, as secondary endpoints, the correlation between the maximum TP value and the findings of video-endoscopic and video-fluoroscopic examinations of swallowing will be analyzed at each evaluation point, as well as changes in the maximum TP value from before RT to during RT and at 0, 1, and 6 months after RT. Discussion: This trial aimed to investigate the usefulness of evaluation by measuring TP for dysphagia associated with HNC treatment. We expect that an easier evaluation for dysphagia will improve rehabilitation programs for dysphagia. Overall, we expect this trial to contribute to the improvement of patients’ quality of life (QOL).
Coronavirus disease 2019 (COVID‑19) generally presents with fever, shortness of breath and a sore throat. These symptoms are also common in oral and pharyngeal infections, such as peritonsillar abscess (PA). The present study describes a case of PA and COVID‑19 co‑infection. Although COVID‑19 was initially suspected in the patient due to the presenting symptoms of fever, sore throat, dysgeusia and dysosmia, an oral examination and computed tomography scan detected PA. The patient was conservatively managed with intravenous antibiotics without transoral drainage of the abscess. Anti‑COVID‑19 medication was not administered as the COVID‑19 infection in the patient was not severe. Laboratory findings revealed high levels of leukocytes, C‑reactive protein (CRP) and procalcitonin. On the whole, the association between laboratory findings (including leukocyte count, CRP and procalcitonin levels) and bacterial co‑infection with COVID‑19 remains unclear, and further studies are warranted. Oral examinations and transoral procedures are often avoided due to the high risk of the aerosolisation of COVID‑19 viral particles. However, an appropriate evaluation is essential in order to avoid the underdiagnosis of life‑threatening bacterial infections that co‑exist with COVID‑19.
Intraoperative transcranial motor-evoked potential (TcMEP) monitoring can effectively prevent neurological complications by enabling the evaluation of neurological deficits in all pathways from the motor cortex to the periphery. However, studies regarding its applicability in head and neck surgery are insufficient. This case report discusses a patient who was intraoperatively diagnosed with a right cervical vagus nerve schwannoma previously at another hospital. The patient then developed right laryngeal paralysis after the surgery without neuromonitoring. No significant recovery of the paralysis was observed, and after eight months of being referred to our institution, the patient opted for surgical retreatment following tumor growth and accompanying symptoms such as cervical swelling and discomfort. The patient was examined to evaluate the nerve damage in his previous surgery TcMEP monitoring as well as direct stimulation (DS). The right vagus nerve (RVN) showed no response on TcMEP monitoring throughout the surgery despite a significant response to DS at the tumor site. These findings suggest that the RVN had been damaged medial to the tumor site, and the damage occurred because of traction and ischemia during the previous surgery. Thus, contrary to our belief, medial nerve damage may be present even when local and peripheral nerve preservation is observed through peripheral neuromonitoring. This suggests that DS alone during neuromonitoring in head and neck surgery is insufficient. A multimodal evaluation approach, including TcMEP monitoring, is effective in not only preventing neurological complications but also in evaluating neurological deficits in all pathways from the motor cortex to the periphery.